377.76
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$378.52
Offen:
$397.625
24-Stunden-Volumen:
12.49M
Relative Volume:
2.02
Marktkapitalisierung:
$339.08B
Einnahmen:
$450.13B
Nettoeinkommen (Verlust:
$14.91B
KGV:
24.29
EPS:
15.551
Netto-Cashflow:
$23.62B
1W Leistung:
+0.38%
1M Leistung:
-0.35%
6M Leistung:
+20.69%
1J Leistung:
+5.33%
Unitedhealth Group Inc Stock (UNH) Company Profile
Firmenname
Unitedhealth Group Inc
Sektor
Branche
Telefon
1-800-328-5979
Adresse
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
UNH
Unitedhealth Group Inc
|
377.76 | 339.08B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
87.55 | 111.97B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
425.27 | 92.23B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
282.53 | 74.66B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
420.38 | 50.48B | 137.20B | 1.15B | 1.27B | 9.3439 |
Unitedhealth Group Inc Stock (UNH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-27 | Herabstufung | Erste Group | Buy → Hold |
| 2026-07-16 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2026-06-17 | Bestätigt | Leerink Partners | Outperform |
| 2026-06-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-04-27 | Hochstufung | Erste Group | Hold → Buy |
| 2026-04-22 | Hochstufung | Argus | Hold → Buy |
| 2026-04-07 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2026-04-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-07-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2025-06-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2025-05-19 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-05-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-14 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-21 | Herabstufung | Argus | Buy → Hold |
| 2025-01-10 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-01-06 | Bestätigt | Truist | Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2024-06-05 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-04 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-12-18 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2023-10-16 | Hochstufung | UBS | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Bestätigt | UBS | Neutral |
| 2023-07-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | Bestätigt | JP Morgan | Overweight |
| 2023-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-07-17 | Bestätigt | TD Cowen | Outperform |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-01 | Bestätigt | BofA Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-04-21 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Herabstufung | Argus | Buy → Hold |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-03-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-04-17 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-09-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-06-11 | Eingeleitet | SunTrust | Buy |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-17 | Bestätigt | Citigroup | Buy |
| 2018-01-12 | Bestätigt | Evercore ISI | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2017-07-19 | Bestätigt | Mizuho | Buy |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Unitedhealth Group Inc Aktie (UNH) Neueste Nachrichten
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Zacks Investment Research
Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich? - Zacks Investment Research
Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going? - Zacks Investment Research
Stock Market Midday, Oct. 13: Bank Earnings and Chip Pressure Drive Mixed Trading - The Motley Fool
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates - Zacks Investment Research
Middle East Tensions Rattle Markets - Zacks Investment Research
Big Week of Data: Inflation & Q3 Earnings - Zacks Investment Research
Estimates Keep Rising as Q3 Earnings Season Takes Center Stage - Zacks Investment Research
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know - Zacks Investment Research
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research
UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research
CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research
UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? - Zacks Investment Research
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? - Zacks Investment Research
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research
Ensign Builds More Scale as Financial Flexibility Remains Strong - Zacks Investment Research
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock - Zacks Investment Research
UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching. - The Motley Fool
UnitedHealth Group Incorporated (UNH) Stock Price, News, Quote & History - Yahoo! Finance Canada
UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research
Warren Buffett's Record: $1,000 Became About $61 Million. Can Greg Abel Keep Compounding It? - The Motley Fool
Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies - GlobeNewswire Inc.
Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off - GlobeNewswire Inc.
Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region - GlobeNewswire Inc.
UNH vs. MOH: Which Managed Care Stock Looks More Attractive? - Zacks Investment Research
NASP Announces 2026 Industry Award Winners at Record-Breaking inSPire2026 Conference - GlobeNewswire Inc.
UnitedHealth Group stock gains as Q2 2026 beat and raised outlook draw analyst support - ad-hoc-news.de
Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1 - Barchart.com
Why Has UnitedHealth Group (UNH) Become a Talking Point? - Kalkine Media
UnitedHealth Group Incorporated • Robinhood Token (UNH) Preț Azi - bybit.com
UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
What's Going On With UnitedHealth Stock Friday?UnitedHealth Group (NYSE:UNH) - Benzinga
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - Zacks Investment Research
UnitedHealth sells stake in Florida WellMed clinics - Healthcare Finance News
UnitedHealth Group (NYSE:UNH): Still Cheap After Gains? - Kalkine Media
UnitedHealth Group stock slips as Medicare Advantage margins stay in focus - ad-hoc-news.de
Dividend Roundup: Meta Platforms, Verizon, UnitedHealth Group, Coca-Cola, and more - Seeking Alpha
Cantor Fitzgerald reiterates UnitedHealth stock rating on Stars outlook - Investing.com
UnitedHealth Group stock heads into the open after a 1.2 percent drop - ad-hoc-news.de
UnitedHealth Group Share Price Today (UNH) | Live Chart, News & Stock Market - TechGraph
Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18%SNS Insider - GlobeNewswire Inc.
UnitedHealth aims to shine 'sunlight' on No Surprises Act problems - BenefitsPRO
UnitedHealth Group (NYSE:UNH): Is Healthcare’s Resilience Enough? - Kalkine Media
UnitedHealth Reshapes Florida WellMed Operations With TPG Deal - Yahoo Finance
UnitedHealth Reshapes Florida WellMed Operations With TPG Deal - Zacks Investment Research
Optum Health CEO pulls back curtain on turnaround - Fierce Healthcare
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth? - Zacks Investment Research
Finanzdaten der Unitedhealth Group Inc-Aktie (UNH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Unitedhealth Group Inc-Aktie (UNH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Conway Patrick Hugh | Officer |
Aug 21 '26 |
Proposed Sale |
390.00 |
1,169 |
455,910 |
0 |
| Conway Patrick Hugh | Chief Executive Officer, Optum |
Aug 05 '26 |
Sale |
410.00 |
500 |
205,000 |
16,497 |
| Conway Patrick Hugh | Officer |
Aug 05 '26 |
Proposed Sale |
410.00 |
500 |
205,000 |
0 |
| Conway Patrick Hugh | Chief Executive Officer, Optum |
Apr 23 '26 |
Sale |
355.00 |
800 |
284,000 |
17,805 |
| Conway Patrick Hugh | Officer |
Apr 23 '26 |
Proposed Sale |
355.00 |
800 |
284,000 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):